Last reviewed: June 3, 2026
Last updated: June 3, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide injections work by slowing stomach emptying and increasing feelings of fullness, helping patients lose an average of 10-15% of body weight over six months. PlexusDx connects patients with licensed 503A compounding pharmacies that prepare semaglutide injections tailored to individual health profiles. Getting started requires a medical consultation and takes just days from approval to first injection.
Licensed Compounding Pharmacies Versus Commercial Sources
PlexusDx partners exclusively with licensed 503A compounding pharmacies, which prepare medications under strict pharmaceutical standards and state board oversight. Unlike mass-produced medications, compounded semaglutide is formulated in response to a patient's individual prescription, ensuring pharmaceutical-grade quality and sterility. Each compounding pharmacy maintains quality control protocols and compliance with state and federal pharmacy regulations.
Patients choosing compounded semaglutide from PlexusDx avoid the supply chain delays and insurance denials that often block access to brand-name versions. The 503A compounding model allows rapid preparation and shipment to all 50 states without requiring insurance pre-authorization. PlexusDx handles the coordination, so patients never need to locate or contact compounding pharmacies directly.
How Semaglutide Injections Support Weight Loss
Semaglutide belongs to the GLP-1 receptor agonist class, a family of medications that activate hunger-suppression pathways in the brain. The medication slows how quickly the stomach empties food into the intestines, triggering satiety signals that last for hours after eating. Clinical trials show patients on semaglutide reduce calorie intake by approximately 400-500 calories daily without conscious restriction.
Weekly injections deliver consistent GLP-1 signaling throughout the body, which also improves blood sugar stability and reduces cravings for high-calorie foods. The injection format allows precise dosing that oral formulations cannot always match, making it effective for patients who struggle with appetite control despite diet and exercise efforts. Most patients notice reduced hunger within 3-7 days of starting treatment.
PlexusDx Pricing and Access for Semaglutide Injections
PlexusDx compounded semaglutide injections start at $149 per month across all three commitment tiers, with no membership fees, insurance requirements, or hidden charges. The pricing structure remains flat even as a doctor increases the dose to find the optimal therapeutic level—a model designed to remove cost barriers during the dose-adjustment phase. HSA and FSA accounts cover compounded semaglutide through PlexusDx, reducing out-of-pocket costs for eligible patients.
Treatment begins with a medical consultation conducted by board-certified providers via secure telehealth, followed by prescription generation and pharmacy preparation. Orders ship directly to patients' homes with detailed injection instructions and support resources. PlexusDx operates nationwide and processes new patient applications within 24-48 hours of consultation completion.
Personalized Dosing and the Precision Peptide Genetic Test
PlexusDx offers the Precision Peptide Genetic Test ($99 add-on after the first month) to identify genetic variants that influence how individual patients respond to GLP-1 therapy. The test examines 14 metabolic and appetite-control pathways, including variants in the GLP1R gene (rs6923761), GIPR gene (rs1800437), FTO gene (rs9939609), and MC4R gene (rs17782313). These insights help doctors personalize starting doses and anticipate which patients may benefit from dual-compound therapy.
Genetic predispositions revealed by the test do not determine treatment outcome but inform whether a patient's body chemistry may respond better to semaglutide alone or to combination GLP-1 therapy. Patients with certain MC4R variants, for example, may show stronger appetite suppression on higher GLP-1 doses, while GIPR variants predict response to dual-compound protocols. Precision testing reduces trial-and-error adjustments and accelerates the path to sustainable weight loss results.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Can I get semaglutide injections without a doctor's prescription?
No. PlexusDx requires a medical consultation with a board-certified provider who reviews your health history and determines if semaglutide is appropriate for you. The consultation is conducted via secure telehealth, and approvals typically take 24-48 hours.
How much weight can I expect to lose with semaglutide injections?
Clinical trials show average weight loss of 10-15% of total body weight over six months of semaglutide treatment, with some patients achieving 20% or greater loss over one year. Individual results depend on adherence, diet quality, activity level, and genetic factors related to appetite control.
How often do I inject semaglutide, and does it hurt?
PlexusDx compounded semaglutide is administered once weekly via subcutaneous injection (under the skin), typically on the abdomen, thigh, or upper arm. The needles are thin and most patients report minimal discomfort. PlexusDx provides detailed injection instruction videos and 24/7 support if questions arise about technique or site rotation.
What are the side effects of semaglutide injections?
Common side effects include nausea, vomiting, constipation, and loss of appetite—effects that typically subside within 1-2 weeks as the body adjusts. Serious adverse events are rare but can include pancreatitis or dehydration in susceptible individuals.
What does the PlexusDx Precision Peptide Genetic Test reveal?
The test analyzes 49 peptides across 14 metabolic pathways, including GLP-1 receptor function, glucose sensing, and appetite-center signaling. Results show whether you carry genetic variants that predict stronger satiety from semaglutide alone or whether combination therapy (semaglutide plus tirzepatide) may optimize your results.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
How Do I Get GLP-1 Medications for Weight Loss?
How to Build Muscle on GLP-1: A Guide to Strength Training During Weight Loss